Beijing Airdoc Technology Co Ltd
HKEX:2251
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
10.22
17.88
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Beijing Airdoc Technology Co Ltd
Cash & Cash Equivalents
Beijing Airdoc Technology Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beijing Airdoc Technology Co Ltd
HKEX:2251
|
Cash & Cash Equivalents
¥941.1m
|
CAGR 3-Years
36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Y
|
Yidu Tech Inc
HKEX:2158
|
Cash & Cash Equivalents
¥1.4B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Medlive Technology Co Ltd
HKEX:2192
|
Cash & Cash Equivalents
¥4.4B
|
CAGR 3-Years
209%
|
CAGR 5-Years
205%
|
CAGR 10-Years
N/A
|
|
|
Guiyang Longmaster Information & Technology Co Ltd
SZSE:300288
|
Cash & Cash Equivalents
¥279.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
B-SOFT Co Ltd
SZSE:300451
|
Cash & Cash Equivalents
¥747m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Winning Health Technology Group Co Ltd
SZSE:300253
|
Cash & Cash Equivalents
¥803.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
Beijing Airdoc Technology Co Ltd
Glance View
Beijing Airdoc Technology Co. Ltd. engages in the provision of AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions. The company is headquartered in Beijing, Beijing and currently employs 369 full-time employees. The company went IPO on 2021-11-05. The firm's main product is Airdoc-AIFUNDUS 1.0. The firm's product can be used in the diagnosis of glaucoma, cataract, ICVD and ASCVD, diabetic retinopathy of pregnancy, hypertensive retinopathy of pregnancy and other diseases. In addition, the Company has developed a deep pipeline of other Software-as-a-medical devices (SaMDs) and health risk assessment solutions to address various healthcare needs for the whole population, including hospitals, community clinics, health checkup centers, insurance companies, optometry centers and pharmacies.
See Also
What is Beijing Airdoc Technology Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
941.1m
CNY
Based on the financial report for Dec 31, 2023, Beijing Airdoc Technology Co Ltd's Cash & Cash Equivalents amounts to 941.1m CNY.
What is Beijing Airdoc Technology Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
36%
Over the last year, the Cash & Cash Equivalents growth was -26%. The average annual Cash & Cash Equivalents growth rates for Beijing Airdoc Technology Co Ltd have been 36% over the past three years .
You don't have any saved screeners yet
